FdaApplication
ANDA 220119
Identifiers
- fda_app_no: ANDA220119
Properties
| Property | Value |
|---|---|
| applicant_name | BIOCON PHARMA LIMITED |
| application_type | ANDA |
Products (7)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 61.25MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 23.75MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 48.75MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 145MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 195MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 245MG | CAPSULE, EXTENDED RELEASE |
| CARBIDOPA AND LEVODOPA | CARBIDOPA,LEVODOPA | 95MG | CAPSULE, EXTENDED RELEASE |
7 products